Merck to acquire Cubist for $8.4 Billion to strengthen antibiotic pipeline
Posted on09 Dec 2014
Comments0
Merck & Company said on Monday that it had agreed to acquireCubist Pharmaceuticals for $8.4 billion, plus the assumption of $1.1 billion... Read More